HCPLive

Study Identifies Photoprotection-Deficient Patients with Cutaneous Lupus Erythematosus

THURSDAY, July 18 (HealthDay News) -- Several subgroups of patients with cutaneous lupus erythematosus (CLE) are deficient in their use of photoprotection, according to a study published in the June issue of the Journal of the American Academy of Dermatology.

Shirley Y. Yang, from the University of Texas Southwestern Medical Center in Dallas, and colleagues examined photoprotective practices of 105 patients with CLE. Demographics and clinical characteristics were collected from patients to identify those with the lowest overall sun-protection habit scores.

The researchers found that CLE patients with medium and dark skin (Fitzpatrick skin types III to VI) and those aged 31 to 50 years had significantly lower sun-protection habit scores, indicating that they were the least likely to practice overall photoprotection. Compared with females, male patients with CLE were deficient in sunscreen use, but were more likely to wear hats. Dark-skinned patients were significantly less likely to use sunscreen and sunglasses than those with Fitzpatrick skin types I to IV. Hat wearing was least likely among patients aged 41 to 50 years.

"Cultural customs and misconceptions shared by those from the general population have a significant influence on the photoprotective habits of this CLE population," the authors write. "These need to be addressed to improve photoprotection rates in these at-risk individuals."

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Most Popular

Recommended Reading

Patients with multiple sclerosis face a variety of challenges in their daily lives, especially when they experience a relapse. How they and their healthcare professionals approach these relapses can impact their overall quality of life even after the relapse passes.
Multiple sclerosis is a condition that affects a person's life over the course of many years. For those with the relapsing form that can include managing symptoms and potential relapses that come during treatment.
Medical marijuana has shown some benefits in the treatment of other health conditions, but its efficacy for patients with multiple sclerosis is still to be determined.
The issue of marijuana use is complicated for many reasons. One of the biggest, according to a recent survey is the willingness of patients and healthcare providers alike to even discuss the topic.
$vAR$